fda compounding semaglutide enforcement 2025 news 4-3-2026 💔❤️‍🩹👹, xoxo reta rat, #wellness #glp1 #medicine #health #news Compounded Semaglutide: Safety & Regulation

This website is a repository of publicly available information and is not intended to form a physician-patient relationship with any individual

Ozempic is a specific brand of GLP-1 receptor agonist used to manage type 2 diabetes and obesity

The injection site should be rotated each week

the BNF and SmPCs for analogous agents such as tirzepatide (Mounjaro) provide relevant class-level context

Self-prescribing or obtaining unregulated medicines online carries significant safety risks and is strongly discouraged

79% do so when prescribed for obesity 27% of respondent plans that cover for diabetes have utilization management programs in place